Effect of High-intensity Laser Therapy on Patients With Myogenic Temporomandibular Joint Dysfunction
NCT ID: NCT06495788
Last Updated: 2024-07-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
40 participants
INTERVENTIONAL
2024-07-12
2024-12-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Laser Therapy on TMJ Disorders After Head and Neck Cancer.
NCT05868460
Efficacy of Different Low Level Laser Therapy Sessions
NCT06327204
Laser Therapy and Temporomandibular Disorders
NCT05620758
High Intensity Laser Versus Ischemic Compression on Myofascial Trigger Points in the Upper Trapezius
NCT06552780
Effect of Conventional Therapy and Low Level Laser Therapy on Pain and Function in Patients With Temporomandibular Joint Dysfunction
NCT03287531
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
High-intensity laser therapy (HILT) is a laser with a wavelength of 1064 nm and has recently been used in the treatment of musculoskeletal diseases. Its primary effect is the analgesic effect and reactive vasodilation by affecting the cutaneous nerve endings. Another mechanism of action is based on tissue stimulation. This stimulation occurs at the level of cells, vascular tissue, interstitial tissue, and the immune system. It increases regeneration and beta-endorphin release by inducing protein synthesis in synovial fluid, thus exerting analgesic and anti-inflammatory effects.
Since there is a lack of literature studying the effect of HILT on masseter and temporalis muscles activity in patients with myogenic TMD so, this study may provide a baseline for a new technique in rehabilitation intervention in patients with myogenic TMD.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High-intensity laser therapy group
Patients will receive pulsed high-intensity laser therapy in addition to conventional treatment
High-intensity laser therapy (HILT)
* Pulsed high-intensity laser therapy (HILT) will be applied 3 sessions per week for 8 weeks with pulsed emission (1064 nm), very high peak power (3 kW), a short duration (120-150 ms), and low frequency (10-40 Hz).The probe is fixed vertically at 90° to the most painful points while the patients sit on a chair and wear safety eyewear.
* Conventional treatment ( 3 days per week for 8 weeks).: in the form of
* Hot pad: It will be used over the temporomandibular joint (TMJ) for 5 minutes at the beginning of each session.
* Ultrasound therapy (US): it will be applied over the TMJ with pulsed intensity of 1.0 W/cm2 at a 1MHz frequency for 5 min/session.
* TENS: one electrode is placed over the TMJ and the other just above the mandibular angle. it will be applied with a low frequency of 50 HZ, tolerable intensity for 15 minutes.
* Exercise therapy: anterior, medial and lateral glide of the mandible. Each glide will be done 10-15 repetitions, 5-6 times in a session, 10 minutes as a total.
placebo high-intensity laser therapy group
Patients will receive placebo high-intensity laser therapy in addition to conventional treatment
placebo high-intensity laser therapy
The same treatment procedure will be applied in the placebo group as in the experimental group, but the laser device is turned off during applications, in addition to the conventional treatment in the form of hot pad, US, TENS, and exercise therapy.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High-intensity laser therapy (HILT)
* Pulsed high-intensity laser therapy (HILT) will be applied 3 sessions per week for 8 weeks with pulsed emission (1064 nm), very high peak power (3 kW), a short duration (120-150 ms), and low frequency (10-40 Hz).The probe is fixed vertically at 90° to the most painful points while the patients sit on a chair and wear safety eyewear.
* Conventional treatment ( 3 days per week for 8 weeks).: in the form of
* Hot pad: It will be used over the temporomandibular joint (TMJ) for 5 minutes at the beginning of each session.
* Ultrasound therapy (US): it will be applied over the TMJ with pulsed intensity of 1.0 W/cm2 at a 1MHz frequency for 5 min/session.
* TENS: one electrode is placed over the TMJ and the other just above the mandibular angle. it will be applied with a low frequency of 50 HZ, tolerable intensity for 15 minutes.
* Exercise therapy: anterior, medial and lateral glide of the mandible. Each glide will be done 10-15 repetitions, 5-6 times in a session, 10 minutes as a total.
placebo high-intensity laser therapy
The same treatment procedure will be applied in the placebo group as in the experimental group, but the laser device is turned off during applications, in addition to the conventional treatment in the form of hot pad, US, TENS, and exercise therapy.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged between 20 to 45 years old .
* Visual analogue scale (VAS) score \>3 for unilateral myogenic pain of the temporomandibular joint (TMJ).
* Pain lasting at least 3 months.
* Patients were diagnosed as unilateral myogenic pain.
Exclusion Criteria
* History of jaw dislocation.
* History of jaw fracture.
* Previous therapy with occlusal splint.
* Concomitant therapy of bruxism.
* Presence of removable oral prosthesis.
* Metal implants in the skull.
* Presence of hearing aids.
* Malignancy.
* Pregnancy.
* Diabetic patients.
* Hypertensive patients.
* Systemic rheumatologic disease
* Systemic infection.
* Inserted cardiac pacemaker.
* Presence of coagulation disorders.
* Trigeminal neuritis.
* Cognitive dysfunction.
* Bilateral TMD.
20 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohaya Ahmed Mohamed
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amir Saleh, professor
Role: STUDY_CHAIR
Cairo University
Naglaa Awais, PHD
Role: STUDY_DIRECTOR
Cairo University
Hala Hazzaa, professor
Role: STUDY_DIRECTOR
Al-Azhar University
Yasser Lasheen, PHD
Role: STUDY_DIRECTOR
Cairo University
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P.T.REC/012/004882
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.